Hyperion DeFi, Inc.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arct… Read more
Hyperion DeFi, Inc. (HYPD) - Total Liabilities
Latest total liabilities as of September 2025: $12.03 Million USD
Based on the latest financial reports, Hyperion DeFi, Inc. (HYPD) has total liabilities worth $12.03 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hyperion DeFi, Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how Hyperion DeFi, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hyperion DeFi, Inc. Competitors by Total Liabilities
The table below lists competitors of Hyperion DeFi, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pierre & Vacances
LSE:0OQ0
|
UK | €4.19 Billion |
|
Asian Phytoceuticals Public Company Limited
BK:APCO
|
Thailand | ฿65.91 Million |
|
Skillsoft Corp.
NYSE:SKIL
|
USA | $620.60 Million |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
USA | $66.27K |
|
WVS Financial Corp
OTCQX:WVFC
|
USA | $316.87 Million |
|
APEX Wind Power Equipment Manufacturing
TWO:7702
|
Taiwan | NT$1.12 Billion |
|
Immunovia AB (publ)
PINK:IMMVF
|
USA | $23.42 Million |
|
Autech Corporation
KQ:067170
|
Korea | ₩482.93 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Hyperion DeFi, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hyperion DeFi, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hyperion DeFi, Inc. (2020–2024)
The table below shows the annual total liabilities of Hyperion DeFi, Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $16.76 Million | -15.25% |
| 2023-12-31 | $19.78 Million | +43.32% |
| 2022-12-31 | $13.80 Million | +23.31% |
| 2021-12-31 | $11.19 Million | -39.83% |
| 2020-12-31 | $18.60 Million | -- |